MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
0.6054
+0.0104
+1.75%
Opening 11:13 01/07 EST
OPEN
0.5900
PREV CLOSE
0.5950
HIGH
0.6118
LOW
0.5851
VOLUME
319.23K
TURNOVER
--
52 WEEK HIGH
1.800
52 WEEK LOW
0.3067
MARKET CAP
35.40M
P/E (TTM)
-0.8410
1D
5D
1M
3M
1Y
5Y
1D
After-Hours Biotech Rally: Alumis, Genelux, Bright Minds, Context Therapeutics Post Big Gains
NASDAQ · 1d ago
Weekly Report: what happened at FEMY last week (1229-0102)?
Weekly Report · 2d ago
Femasys files to sell 68.42M shares of common stock for holders
TipRanks · 12/31/2025 21:40
Weekly Report: what happened at FEMY last week (1222-1226)?
Weekly Report · 12/29/2025 09:27
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 12/24/2025 12:05
Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/24/2025 11:01
Femasys Launches At-the-Market Common Stock Offering
TipRanks · 12/23/2025 21:38
Femasys Files Prospectus For Offer, Sale Of Shares In $9.8M Common Stock Offering
Benzinga · 12/23/2025 21:19
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.